Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report) saw a significant growth in short interest during the month of September. As of September 15th, there was short interest totaling 1,160,000 shares, a growth of 4,228.4% from the August 31st total of 26,800 shares. Based on an average trading volume of 2,850,000 shares, the days-to-cover ratio is currently 0.4 days. Approximately 26.4% of the company’s shares are sold short. Approximately 26.4% of the company’s shares are sold short. Based on an average trading volume of 2,850,000 shares, the days-to-cover ratio is currently 0.4 days.
Check-Cap Price Performance
NASDAQ:CHEK opened at $2.25 on Thursday. The firm has a market capitalization of $13.16 million, a price-to-earnings ratio of -0.75 and a beta of 0.49. The business has a 50 day simple moving average of $1.10 and a 200-day simple moving average of $0.89. Check-Cap has a 1 year low of $0.56 and a 1 year high of $3.13.
Get Check-Cap alerts:
About Check-Cap
(Get Free Report)
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
Read More
Five stocks we like better than Check-Cap
Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
Datavault AI: The New AI Contender Backed by Big Funding
Comparing and Trading High PE Ratio Stocks
CoreWeave: Why the New King of AI Infrastructure Has Room to Run
Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
Top 3 Dividend Achievers for October: High Yields, Growth Ahead
